Mandel Sher

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 216 citations · Full text

Asthma, Pulmonary Care, Phase 2B +6

Gefapixant in two randomised dose-escalation studies in chronic cough

John A. Smith, Michael M. Kitt, P. Butera et al. · European Respiratory Journal · 2020 · 130 citations · Full text

Pulmonary vascular disease in complete atrioventricular canal defect

Edgar A. Newfeld, Mandel Sher, Milton H. Paul et al. · The American Journal of Cardiology · 1977 · 119 citations

Pulmonary Circulation, Pulmonary Medicine, Medicine +2

Diversity in presenting manifestations of systemic lupus erythematosus in children

Shahid Iqbal, Mandel Sher, Robert A. Good et al. · The Journal of Pediatrics · 1999 · 100 citations

Rheumatology, Clinical Finding, Autoimmune Disease +8

Severe food allergies by skin contact

Belen M. Tan, Mandel Sher, Robert A. Good et al. · Annals of Allergy Asthma & Immunology · 2001 · 85 citations

Food Allergy, Allergy, Skin Contact +9